WO2000067708A3 - Oral steroidal hormone compositions and methods of use - Google Patents

Oral steroidal hormone compositions and methods of use Download PDF

Info

Publication number
WO2000067708A3
WO2000067708A3 PCT/US2000/012404 US0012404W WO0067708A3 WO 2000067708 A3 WO2000067708 A3 WO 2000067708A3 US 0012404 W US0012404 W US 0012404W WO 0067708 A3 WO0067708 A3 WO 0067708A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
steroidal hormone
hormone compositions
oral
Prior art date
Application number
PCT/US2000/012404
Other languages
French (fr)
Other versions
WO2000067708A2 (en
Inventor
Vassem Ali
Original Assignee
Univ Texas
Vassem Ali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Vassem Ali filed Critical Univ Texas
Priority to AU48252/00A priority Critical patent/AU4825200A/en
Publication of WO2000067708A2 publication Critical patent/WO2000067708A2/en
Publication of WO2000067708A3 publication Critical patent/WO2000067708A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Abstract

Provided are oral dentifrice compositions comprising a therapeutically effective amount of estrogen or an estrogen-containing substance. A variety of different methods of using the compositions, for example in the treatment or prevention of tooth loss or osteoporosis, are also provided. Additionally, therapeutic kits comprising one or more of the present compositions are provided.
PCT/US2000/012404 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use WO2000067708A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48252/00A AU4825200A (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13308599P 1999-05-07 1999-05-07
US60/133,085 1999-05-07

Publications (2)

Publication Number Publication Date
WO2000067708A2 WO2000067708A2 (en) 2000-11-16
WO2000067708A3 true WO2000067708A3 (en) 2001-02-08

Family

ID=22456942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012404 WO2000067708A2 (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Country Status (2)

Country Link
AU (1) AU4825200A (en)
WO (1) WO2000067708A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303500A2 (en) * 2000-11-17 2004-01-28 Warner-Lambert Company Llc Treatment of sexual dysfunction using bombesin antagonist
WO2003011282A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
JP2022548314A (en) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Methods for prolonging pregnancy and treating complications of menstruation or pregnancy

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (en) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Method and composition for treatment or prevention of dental plaque, calculus and gingivitis
EP0455503A1 (en) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (en) * 1993-01-19 1994-08-04 The Gillette Company Mouthrinse
EP0671175A2 (en) * 1989-11-17 1995-09-13 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (en) * 1998-07-17 2000-01-27 Jenapharm Gmbh Treating or preventing oral atrophic symptoms, e.g. marginal periodontal disease, by local administration of estrogen such as estriol

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (en) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Method and composition for treatment or prevention of dental plaque, calculus and gingivitis
EP0671175A2 (en) * 1989-11-17 1995-09-13 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
EP0455503A1 (en) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (en) * 1993-01-19 1994-08-04 The Gillette Company Mouthrinse
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (en) * 1998-07-17 2000-01-27 Jenapharm Gmbh Treating or preventing oral atrophic symptoms, e.g. marginal periodontal disease, by local administration of estrogen such as estriol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Also Published As

Publication number Publication date
AU4825200A (en) 2000-11-21
WO2000067708A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
WO2001070208A3 (en) Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
HUP0104718A3 (en) Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
EP0841936A4 (en) Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations
ITMI961152A0 (en) THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF
DK0748190T3 (en) Progestogen-free formulations of GnRH and estrogen for the treatment of benign gynecological disorders
WO2000042992A3 (en) Compositions and methods for mucosal delivery
HUP0101693A2 (en) Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease
EP1186293A3 (en) Intermittent administration of a growth hormone secretagogue
AU5181200A (en) Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
WO1999063976A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
AU6152200A (en) Azolylbenzamides and analogues and their use for treating osteoporosis
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
WO2002074292A3 (en) Hormone replacement therapy
AU1460801A (en) Cholesterol reducing sterol compositions, preparation and method of use
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
HUP0200173A3 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
MXPA02001631A (en) Pharmaceutical compositions for oral and topical administration.
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
SI1227814T1 (en) Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof
WO2001082910A3 (en) Combination of progesterone and mifepristone for cancer therapy
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP